We are live on
!
Find out more
UONDDL
University of Notre Dame du Lac Portfolio holdings
AUM
$66.8M
1-Year Est. Return
43.52%
This Fund
S&P 500
This Quarter
Est. Return
-15.68%
1 Year Est. Return
+43.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$324M
AUM Growth
+$8.15M
(+2.6%)
Cap. Flow
+$87M
Cap. Flow
% of AUM
26.81%
Top 10 Holdings %
Top 10 Hldgs %
44.08%
Holding
64
New
13
Increased
29
Reduced
13
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$17.9M |
| 2 |
Brookfield
BN
|
+$15.4M |
| 3 |
Charter Communications
CHTR
|
+$14.4M |
| 4 |
Trupanion
TRUP
|
+$10.3M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$8.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDCO
Medicines Co
MDCO
|
+$14.1M |
| 2 |
Tyler Technologies
TYL
|
+$8.52M |
| 3 |
LPL Financial
LPLA
|
+$8.23M |
| 4 |
Deere & Co
DE
|
+$7.92M |
| 5 |
Crown Holdings
CCK
|
+$7.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.57% |
| 2 | Communication Services | 21.17% |
| 3 | Technology | 17.25% |
| 4 | Consumer Discretionary | 10.67% |
| 5 | Healthcare | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYOK
51
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $731K | 0.23% |
15,597
-2,666
| -15% | -$171K |
|
52
Axsome Therapeutics
AXSM
$11.2B
| $714K | 0.22% |
+12,137
| New | +$989K |
|
|
EXAS
53
DELISTED
Exact Sciences
EXAS
| $649K | 0.2% |
11,184
-877
| -7% | -$71.2K |
|
54
Heron Therapeutics
HRTX
$64.7M
| $614K | 0.19% |
52,288
+6,428
| +14% | +$121K |
|
|
DBVT
55
DBV Technologies
DBVT
$889M
| $456K | 0.14% |
11,644
-1,289
| -10% | -$116K |
|
|
AMRN
56
Amarin Corp
AMRN
$297M
| $249K | 0.08% |
3,116
+892
| +40% | +$296K |
|
|
57
Crown Holdings
CCK
$13.1B
| – | – |
-106,928
| Closed | -$7.76M |
|
58
Cerus
CERS
$546M
| – | – |
-220,213
| Closed | -$929K |
|
|
59
Deere & Co
DE
$167B
| – | – |
-45,727
| Closed | -$7.92M |
|
|
60
LPL Financial
LPLA
$29.7B
| – | – |
-89,235
| Closed | -$8.23M |
|
61
Rhythm Pharmaceuticals
RYTM
$8.1B
| – | – |
-44,390
| Closed | -$1.02M |
|
|
62
Tyler Technologies
TYL
$13B
| – | – |
-28,389
| Closed | -$8.52M |
|
|
TCDA
63
DELISTED
Tricida, Inc. Common Stock
TCDA
| – | – |
-26,658
| Closed | -$1.01M |
|
|
MDCO
64
DELISTED
Medicines Co
MDCO
| – | – |
-165,687
| Closed | -$14.1M |
|
Similar funds
PPL
ACH
TM
SVG
DLDF
AGFIA
ARC
ST
University of Notre Dame du Lac's Q1 2020 Portfolio in Review
As of Q1 2020, University of Notre Dame du Lac held 64 positions worth $324M, up 2.6% from $316M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
University of Notre Dame du Lac deployed $87M of net new capital in Q1 2020, opening 13 new positions and adding to 29 existing holdings. Its largest new stake was Netflix: 504,580 shares worth $18.9M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 23% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the largest reduction was Amazon, an estimated $4.02M trimmed.
- University of Notre Dame du Lac's largest Q1 2020 buy was Netflix: 504,580 shares worth $18.9M.
- University of Notre Dame du Lac added most to Alphabet (Google) Class C in Q1 2020, an estimated $6.4M increase.
- University of Notre Dame du Lac's biggest Q1 2020 reduction was Amazon, cutting an estimated $4.02M.
- University of Notre Dame du Lac fully exited Medicines Co in Q1 2020, selling an estimated $14.1M.
- University of Notre Dame du Lac's ten largest holdings make up 44% of its $324M portfolio in Q1 2020.
- University of Notre Dame du Lac opened 13 new positions and closed 8 in Q1 2020.
- University of Notre Dame du Lac's portfolio value rose 2.6% quarter-over-quarter to $324M.
Based on University of Notre Dame du Lac's 13F filing for Q1 2020, filed 15 May 2020.